Proprev AB

Sweden

Back to Profile

1-4 of 4 for Proprev AB Sort by
Query
Aggregations
Jurisdiction
        United States 3
        World 1
Date
2024 1
Before 2021 3
IPC Class
A61K 35/74 - Bacteria 4
A21D 13/02 - Products made from whole mealProducts containing bran or rough-ground grain 3
A21D 13/40 - Products characterised by the type, form or use 3
A23L 33/135 - Bacteria or derivatives thereof, e.g. probiotics 3
A23L 33/21 - Addition of substantially indigestible substances, e.g. dietary fibres 3
See more
Status
Pending 1
Registered / In Force 3
Found results for  patents

1.

Prevotella copri compositions

      
Application Number 18591306
Grant Number 12370226
Status In Force
Filing Date 2024-02-29
First Publication Date 2024-08-29
Grant Date 2025-07-29
Owner PROPREV AB (Sweden)
Inventor
  • Björck, Inger
  • Nilsson, Anne
  • Backhed, Fredrik
  • Kovatcheva-Datchary, Petia

Abstract

P. copri). The food product, food ingredient and food supplement are suitable for ingestion and the medicament is suitable for use as a suppository or enema or enclosed in a capsule.

IPC Classes  ?

  • A61K 35/74 - Bacteria
  • A21D 13/02 - Products made from whole mealProducts containing bran or rough-ground grain
  • A21D 13/40 - Products characterised by the type, form or use
  • A23L 7/117 - Flakes or other shapes of ready-to-eat typeSemi-finished or partly-finished products therefor
  • A23L 33/135 - Bacteria or derivatives thereof, e.g. probiotics
  • A23L 33/21 - Addition of substantially indigestible substances, e.g. dietary fibres

2.

TREATMENT OF OBESITY, THE METABOLIC SYNDROME, TYPE 2 DIABETES, CARDIOVASCULAR DISEASES, DEMENTIA, ALZHEIMER'S DISEASE AND INFLAMMATORY BOWEL DISEASE BY USING AT LEAST ONE BACTERIAL STRAIN FROM PREVOTELLA

      
Application Number 16175299
Status Pending
Filing Date 2018-10-30
First Publication Date 2019-05-23
Owner PROPREV AB (Sweden)
Inventor
  • Björck, Inger
  • Nilsson, Anne
  • Backhed, Fredrik
  • Kovatcheva-Datchary, Petia

Abstract

A product for use in the treatment of obesity, the metabolic syndrome, type 2 diabetes, cardiovascular diseases, dementia, Alzheimer's disease and inflammatory bowel disease comprising at least one isolated bacterial strain from the species Prevotellaceae, wherein the strain is selected from the group consisting of Prevotella copri, Prevotella stercorea, Prevotella histicola, Prevotella ruminicola, Prevotella Bryantii 25A and Prevotella distasonis. The product may be a food product.

IPC Classes  ?

  • A61K 35/74 - Bacteria
  • A21D 13/04 - Products made from materials other than rye or wheat flour
  • A23L 33/135 - Bacteria or derivatives thereof, e.g. probiotics
  • A23L 33/21 - Addition of substantially indigestible substances, e.g. dietary fibres
  • A21D 13/40 - Products characterised by the type, form or use
  • A23L 7/117 - Flakes or other shapes of ready-to-eat typeSemi-finished or partly-finished products therefor
  • A21D 13/02 - Products made from whole mealProducts containing bran or rough-ground grain

3.

Prevotella

      
Application Number 14895132
Grant Number 10137157
Status In Force
Filing Date 2014-05-27
First Publication Date 2016-04-28
Grant Date 2018-11-27
Owner PROPREV AB (Sweden)
Inventor
  • Björck, Inger
  • Nilsson, Anne
  • Backhed, Fredrik
  • Kovatcheva-Datchary, Petia

Abstract

Prevotella distasonis. The product may be a food product.

IPC Classes  ?

  • A61K 35/74 - Bacteria
  • A21D 13/40 - Products characterised by the type, form or use
  • A21D 13/02 - Products made from whole mealProducts containing bran or rough-ground grain
  • A21D 13/04 - Products made from materials other than rye or wheat flour
  • A23L 7/117 - Flakes or other shapes of ready-to-eat typeSemi-finished or partly-finished products therefor
  • A23L 33/135 - Bacteria or derivatives thereof, e.g. probiotics
  • A23L 33/21 - Addition of substantially indigestible substances, e.g. dietary fibres

4.

TREATMENT OF OBESITY, THE METABOLIC SYNDROME, TYPE 2 DIABETES, CARDIOVASCULAR DISEASES, DEMENTIA, ALZHEIMER'S DISEASE AND INFLAMMATORY BOWEL DISEASE BY USING AT LEAST ONE BACTERIAL STRAIN FROM PREVOTELLA

      
Application Number SE2014050650
Publication Number 2014/196913
Status In Force
Filing Date 2014-05-27
Publication Date 2014-12-11
Owner PROPREV AB (Sweden)
Inventor
  • Björck, Inger
  • Nilsson, Anne
  • Bäckhed, Fredrik
  • Kovatcheva-Datchary, Petia

Abstract

A product for use in the treatment of obesity, the metabolic syndrome, type 2 diabetes, cardiovascular diseases, dementia, alzheimers disease and inflammatory bowel diseasecomprising at least one isolated bacterial strain from the species Prevotellaceae, wherein the strainis selected from the group consisting of Prevotella copri, Prevotella stercorea,Prevotella histicola, Prevotella ruminicola, Prevotella Bryantii 25A and Prevotella distasonis. The product may be a food product.

IPC Classes  ?